We have studied the time course and relative effects of hypoinsulinaemia and hyperglycaemia on concentrations of uncoupling protein (UCP) and glucose transporter (GLUT4) and their mRNAs in brown adipose tissue (BAT) during the early phase of diabetes induced by streptozotocin. Two days after intravenous injection of streptozotocin, plasma insulin concentration was at its lowest and glycaemia was higher than 22 mmol/l. After 3 days, a 60 % decrease in BAT UCP mRNA concentration and a 36 % decrease in UCP was observed. Concomitantly, there was an 80 % decrease in GLUT4 mRNA and a 44% decrease in GLUT4 levels. When hyperglycaemia was prevented by infusing phlorizin into diabetic rats, BAT UCP mRNA and protein levels were further decreased (respectively 90 % and 60 % lower than in control rats). In contrast, the marked decreases in GLUT4 mRNA and protein concentrations
INTRODUCTION
Brown adipose tissue (BAT) is specialized in heat production (Himms-Hagen, 1990) . A 33 kDa protein, called uncoupling protein (UCP), is the key element of BAT thermogenic activity. This protein is uniquely expressed in the inner membrane of mitochondria of BAT where it dissipates the proton gradient generated by the respiratory chain (Nichols and Locke, 1984; Cannon and Nedergaard, 1985; Klaus et al., 1991b) . In BAT, energy is essentially provided by the oxidation of non-esterified fatty acids (Nichols and Locke, 1984) and to a lesser extent by the oxidation of glucose (Ferre et al., 1985; Young et al., 1985) . BAT is activated upon exposure of animals to cold or during hyperphagia (diet-induced thermogenesis). The major mechanism for activation of BAT is the sympathetic nervous system. Noradrenaline release at the nerve endings stimulates BAT lipolysis and fatty acid oxidation via fl-adrenergic receptors (Girardier, 1983) . Insulin has also been postulated to be a factor controlling thermogenesis and UCP synthesis in BAT (Jamal and Saggerson, 1988; Rothwell and Stock, 1988; Geloen and Trayhurn, 1990a) . In diabetic rats, cold tolerance and noradrenaline-stimulated thermogenesis are markedly impaired (Poe and Davis, 1962) , and this is due to a decreased concentration of UCP or GDP-binding sites in BAT (Seydoux et al., 1984; Jamal and Saggerson, 1988; Geloen and Trayhurn, 1990a) . The maintenance of normal concentrations of UCP or GDPbinding sites in BAT has been shown to require intact sympathetic activity (Young et al., 1982; Yoshida et al., 1985) and normal plasma insulin levels (Geloen and Trayhurn, 1990a,b) . However, these studies did not determine if insulin controlled BAT injection. Blood (300 1,) was sampled from the right jugular vein before and 5 min after glucose injection. Blood was immediately centrifuged and plasma was frozen until used for glucose and insulin determinations. Plasma insulin concentration in all diabetic rats remained at the low basal value despite very high plasma glucose concentration (22 mmol/l) (results not shown). This group was termed 'diabetic' rats.
Group 3 were a group of STZ-diabetic rats infused through the jugular vein with phlorizin (Sigma) at variable rates: 0.5-2.0 g/day per kg, from 18 h after STZ injection to 72 h. By inhibiting glucose reabsorption from the renal tubule, phlorizin normalized blood glucose level in diabetic rats, without altering plasma insulin concentration. These rats had free access to food during the experimental period. This group was termed 'phlorizin-treated diabetic' rats.
Group 4 were fed non-diabetic rats infused intravenously with phlorizin or vehicle (propylene glycol) as in group 3.
Group 5 were a group of STZ diabetic rats infused intravenously with insulin (Actrapid, Novo, Copenhagen, Denmark) at a constant rate: 0.25 unit/h per kg, from 18 h after STZ injection to 48 h, to maintain their blood glucose level in the normal range. They had free access to food during the experimental period. This group was termed 'insulin-treated diabetic' rats. In some of these insulin-treated diabetic rats, insulin infusion was stopped after 48 h. The rats were killed 6 or 24 h after insulin withdrawal.
Monitoring of blood glucose and plasma insulin concentrations
Blood glucose and plasma insulin were monitored daily throughout the experimental period in rats from groups 2 to 5. Blood glucose was routinely monitored by the glucose oxidase method using a Beckman glucose analyser (Beckman BGA2, Gallway, Ireland). Plasma insulin concentration was determined by radioimmunoassay as described previously (Girard et al., 1973) .
Klilng of animals and tissue sampling
Rats were anaesthetized by an intraperitoneal injection of pentobarbital (60 mg/kg body weight). Blood was sampled from the jugular vein and collected in the presence of 2000 units of aprotinin/ml of blood and EDTA (0.01 M). Blood was immediately centrifuged at 4°C and the plasma frozen at -20°C until insulin determination. After blood sampling, the interscapular BAT was rapidly removed, rinsed in 0.9 % NaCl, wiped and frozen at -80°C.
Quantification of UCP and GLUT4 mRNAs
Total RNA was isolated from BAT using the guanidine thiocyanate method (Chomczynski and Sacchi, 1987 The membranes were washed twice for 30 min each, with 2 x SSC/0.1 % SDS at 42°C and twice for 30 min each with 0.1 x SSC/0. 1 % SDS at 55 "C and autoradiographed for 4-72 h at -80°C with intensifying screens. Quantification of autoradiographs was performed by scanning densitometry using a densitometer (Hoeffer Scientific Instruments). Standardization of Northern blots was performed using an oligonucleotide representing the sequence 1047-1070 of rat 18S rRNA (Chan et al., 1984) , labelled with [32P]ATP by bacteriophage T4 polymerase kinase, to verify the integrity of RNA and that each lane was loaded with the same amount of total RNA. Results of the UCP and GLUT4 probe analyses were corrected for RNA added by dividing by the 18S RNA values.
Quantfflcation of UCP and GLUT4 by immunoblotting BAT was homogenized in 10 vol. ofTris/EDTA/sucrose, pH 7.4. The proteins were quantified using the Bio-Rad assay (Munich, Germany) with BSA as standard. Homogenates (25 ,ug) were submitted to slot-blotting (nitrocellulose membrane, Schleicher & Schuell, Dassel, Germany) using a polyclonal antibody against GLUT4 (East-Acres, Southbridge, MA, U.S.A.) and a polyclonal antibody against UCP (Ricquier et al., 1983) . Detection of GLUT4 was performed with 0.2 ,uCi/ml 1251I-Protein A (Amersham), followed by autoradiography. Quantification was performed with scanning autoradiographs using a densitometer. Detection of UCP was achieved by alkaline phosphatase-linked anti-sheep IgG (Bio-Rad) reacting with 5-bromo-4-chloro-3-indolyl phosphate and p-NitroBlue Tetrazolium chloride (BioRad). Quantification was performed with scanning blots using a reflectancemeter (Hoeffer Scientific Instruments).
Statistical analysis
Results are expressed as means + S.E.M. Statistical analysis was performed by Student's t test for unpaired data.
RESULTS AND DISCUSSION
The present study was undertaken (1) to analyse the time course of the changes in UCP mRNA concentration in BAT of diabetic rats and (2) to assess the relative effects of hypoinsulinaemia and hyperglycaemia on this parameter. The changes in GLUT4 mRNA were followed in parallel as a control of insulin action.
Changes in blood glucose and plasma insulin concentrations Diabetic rats After STZ injection, a typical hyperglycaemia and hypoinsulinaemia appeared from 30 h onwards (Table 1) .
Phlorizin-treated diabetic rats
In phlorizin-treated diabetic rats, the blood glucose concentration was maintained at a mean value of 7.2 mmol/l from the 18th hour onwards (Table 1) . Plasma insulin concentration in phlorizin-treated diabetic rats was not statistically different from the untreated diabetic rats. Table 3 Quantification of UCP and GLUT4 concentrations in BAT of control and diabetic rats UCP and GLUT4 were quantified by scanning reflectancemetry and normalized per mg of homogenate proteins, as described in the Materials and methods section. Values are expressed as % of controls and are means + S.E.M. of the number of rats indicated in parentheses. Some diabetic rats were infused with either phlorizin (STZ + Phl) from 18 to 72 h or insulin (STZ + Ins) from 18 to 48 h, and compared with controls or 48 h or 72 h non-treated diabetic rats. Some insulin-infused diabetic rats had their insulin infusion stopped after 48 h. They were studied 24 h after insulin withdrawal and compared with insulin-infused diabetic rats (STZ+ins). *Difference statistically significant (P< 0.05) when compared with fed nondiabetic rats. tDifference statistically significant (P < 0.05) when compared with non-treated diabetic rats. Figure 1 Representative Northern-blot analysis of UCP and GLUT4 mRNA concentrations in BAT of control and diabetic rats This is a representative example in which RNAs from two different rats taken at random were analysed for each experimental condition. Some diabetic rats were infused with either phlorizin (STZ+Phl) from 18 to 72 h, or insulin (STZ+ Ins) from 18 to 48 h, and compared with controls (C) or non-treated diabetic rats (STZ).
Phlorizin-treated non-diabetic rats After 3 days of phlorizin infusion, blood glucose concentration was 5.5 mmol/l and plasma insulin concentration was 18 ,units/ml (Table 1) . These values were not statistically different from those measured in control rats.
Insulin-treated diabetic rats Blood glucose concentration in diabetic rats was maintained between 18 and 48 h at a mean value of 6.6 mmol/l by using an insulin infusion rate of 0.25 unit/h per kg. The mean plasma insulin concentration reached 45,aunits/ml, a value close to physiological values (Table 1) . When insulin infusion was stopped, a rapid decrease in plasma insulin concentration was observed and a marked hyperglycaemia developed after 1 h ( Table 1 ). The rapid disappearance of plasma insulin allowed us to study short-term effects of insulin deprivation and hyperglycaemia on UCP and GLUT4 mRNA and protein concentrations.
Changes in UCP and GLUT4 mRNA and protein concentrations
Fed non-diabetic rats were used as controls. UCP and GLUT4 mRNA (Table 2 ) and protein ( Some diabetic rats were infused with insulin (STZ + Ins) from 18 to 48 h. Some insulin-infused diabetic rats had their insulin infusion stopped after 48 h. They were studied 6-24 h after insulin withdrawal and compared with insulin-infused diabetic rats (STZ+Ins).
after 10-12 days of diabetes the concentration of UCP and the number of GDP-binding sites was decreased by 35-80 % in BAT (Seydoux et al., 1984; Jamal and Saggerson, 1988; Geloen and Trayhurn, 1990a (Figures 1 and 2 ), the decrease in UCP mRNA and protein concentration was prevented. Previous observations have shown that UCP concentration in BAT was normalized by infusion of increasing amounts of insulin in diabetic mice and rats (Geloen and Trayhurn, 1990a,b) . The precise time course of UCP mRNA concentration during hypoinsulinaemia in vivo was investigated after insulin treatment of diabetic rats was stopped. UCP and GLUT4 mRNA concentrations were not significantly decreased 6 h after insulin infusion was stopped, but after 24 h a reduction of 75 % was observed (Figure 3 ). UCP and GLUT4 concentrations had not changed 24 h after insulin withdrawal (Figure 2 ). Recent in vitro experiments have also emphasized the direct role of insulin on the expression of the UCP gene in adipocytes differentiated from interscapular brown preadipocytes of Phodopus sungorus (Klaus et al., 199 1a) and in brown fat tumour cells derived from a transgenic mouse (Kozak et al., 1992) . However, it was difficult to investigate the separate roles of hypoinsulinaemia and hyperglycaemia on UCP gene expression in vivo in untreated and insulin-treated diabetic rats. The specific role of hyperglycaemia has been studied by infusing phlorizin into diabetic rats. Surprisingly, the decrease in UCP mRNA and protein concentrations in BAT was more pronounced (respectively -90% and -60%) in diabetic rats that had had their glycaemia normalized by phlorizin treatment than in untreated diabetic rats (respectively -60% and -36%). In contrast, the marked decreases in GLUT4 mRNA and protein concentrations in BAT were similar in hyperglycaemic and normoglycaemic diabetic rats (Figures 1 and 2 ). This suggests that hyperglycaemia had a specific effect on UCP mRNA and protein concentrations in BAT. It is noteworthy that phlorizin infusion in non-diabetic rats did not change UCP and GLUT4 mRNA concentrations significantly compared with control rats (results not shown). Thus phlorizin per se was not responsible for the dramatic decrease (-90%) in UCP mRNA in BAT of phlorizin-treated diabetic rats. It has been reported that hyperglycaemia can directly increase or potentiate the effect of insulin on the expression of a number of hepatic genes. Liver GLUT2 gene expression is increased by hyperglycaemia in vivo and in vitro (Oka et al., 1990; Asano Ct al., 1992; Burcelin et al., 1992) , and hyperglycaemia, in the presence of insulin, increases the expression of L-pyruvate kinase (Decaux et al., 1991) , aldolase B (Munnich et al., 1985) and S14 gene (Goto and Mariash, 1992 ). The present study shows that BAT UCP is another glucosedependent gene. The 5'-flanking regions of L-pyruvate kinase and S14 genes have been shown to contain a regulatory sequence of 10 nucleotides responsible for activation in response to elevated glucose metabolism (Thompson and Towle, 1991; Shih and Towle, 1992) . Four segments (-1625 to -1615, -1566 to -1556, -866 to -856, -795 to -785) with 80% sequence similarity to the carbohydrate-response element of S14 and Lpyruvate kinase genes have been found in the 5'-flanking region of UCP gene (Bouillaud et al., 1988) .
